UTI Healthcare Fund - G

NAV ₹280.309 ↑ 1.70 (0.61 %) as on 20 Jan 25

(Erstwhile UTI Pharma & Healthcare Fund)

Table of Contents

Scheme Objective
NAV Price Chart
Returns
- Historical Returns
- Compounded Returns
Growth Of 10k Over Years
Holdings / Portfolio
All Plan & Options
Fund Manager Information
Custodians
Registrar & Transfer Agent (RTA)
Administrator Companies
Auditors

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 15.2% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% .

Below is the key information for UTI Healthcare Fund

NAV as on 20 Jan 25	₹280.309 ↑ 1.70 (0.61 %)
Net Assets (AUM) as on 31 Dec 2024	₹1,236 Cr.
Launch Date	28 Jun 1999
Category	Equity - Sectoral
Rating	☆
Type	Open Ended Fund
Risk	High
AMC	UTI Asset Management Company Ltd

Alpha Ratio	-0.45
Expense Ratio	2.38 %
Sharpe Ratio	2.321
Information Ratio	-0.22
Benchmark	Not Available
Min Investment	₹5,000
Min SIP Investment	₹500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

NAV Price Chart

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 20 Jan 25

Duration	Returns
1 Month	-2.6%
3 Month	-3%
6 Month	12.3%
1 Year	33.3%
3 Year	18.8%
5 Year	25.7%
10 Year
15 Year
Since launch	15.2%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

Year	Returns
2023	42.9%
2022	38.2%
2021	-12.3%
2020	19.1%
2019	67.4%
2018	1.2%
2017	-7.5%
2016	6.2%
2015	-9.7%

Growth of 10k Over Years

Date	Value
31 Dec 19	₹10,000
31 Dec 20	₹16,736
31 Dec 21	₹19,930
31 Dec 22	₹17,475
31 Dec 23	₹24,150
31 Dec 24	₹34,500

Asset Allocation

Asset Class	Value
Cash	2.41%
Equity	97.59%

Sector Allocation

Sector	Value
Health Care	96.03%
Basic Materials	1.27%
Financial Services	0.29%

Top Securities Holdings / Portfolio

Holdings/Securities

Name	Global Industry	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	Drug Manufacturers - Specialty & Generic	11%	₹129 Cr	725,000
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| CIPLA	Drug Manufacturers - General	6%	₹69 Cr	450,660
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| AJANTPHARM	Drug Manufacturers - Specialty & Generic	5%	₹58 Cr	193,047 ↓ -15,318
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	Drug Manufacturers - Specialty & Generic	5%	₹57 Cr	470,234 ↑ 34,734
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| GLENMARK	Drug Manufacturers - Specialty & Generic	4%	₹47 Cr	309,311 ↑ 58,980
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	Drug Manufacturers - Specialty & Generic	4%	₹46 Cr	266,306
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	Medical Care Facilities	3%	₹41 Cr	60,000
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Dec 20 \| FORTIS	Medical Care Facilities	3%	₹40 Cr	611,658 ↓ -22,787
Procter & Gamble Health Ltd (Healthcare) Equity, Since 31 Dec 20 \| PGHL	Drug Manufacturers - Specialty & Generic	3%	₹38 Cr	74,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	Drug Manufacturers - Specialty & Generic	3%	₹38 Cr	61,480

1 - 10 of 44

Ready to Invest?
Talk to our investment specialist

Fund Managers

Name	Since	Tenure
Kamal Gada	2 May 22	2.67 Yr.

Custodians

Company	Address
Bank of Nova Scotia	12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. India	Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of India	Mittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Ltd
Address	138 -Suyesh Solitaire, Nr. Podar International School,Kudasan, Gandhinagar, Gujarat
FAX	N.A
Email	N.A

Administrator Companies

Company	Address
UTI Mutual Fund	UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

Company	Address
Haribhakti & Co. Chartered Accountants	42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and Plan	NAV	6 Month	1 Year	3 Year	5 Year
UTI Healthcare Fund Growth	₹280.309 ↑ 1.70	12.29 %	33.29 %	18.85 %	25.72 %
UTI Healthcare Fund Normal Dividend, Payout	₹216.64 ↑ 1.31	12.29 %	33.29 %	18.85 %	25.72 %
UTI Healthcare Fund Normal Dividend, Reinvestment	₹216.64 ↑ 1.31	12.29 %	33.29 %	18.85 %	25.72 %
Data as on 20 Jan 25

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.

Shepard Technologies Pvt. Ltd : 1808, Solus, Hiranandani Estate, Thane, Maharashtra - 400607

AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.